A detailed history of Black Rock Inc. transactions in Surmodics Inc stock. As of the latest transaction made, Black Rock Inc. holds 1,051,961 shares of SRDX stock, worth $44.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,051,961
Previous 1,080,288 2.62%
Holding current value
$44.2 Million
Previous $39.3 Million 21.4%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$27.44 - $35.56 $777,292 - $1.01 Million
-28,327 Reduced 2.62%
1,051,961 $30.9 Million
Q4 2023

Feb 13, 2024

BUY
$28.47 - $38.49 $1.63 Million - $2.21 Million
57,385 Added 5.61%
1,080,288 $39.3 Million
Q3 2023

Nov 13, 2023

BUY
$28.28 - $38.36 $490,516 - $665,354
17,345 Added 1.72%
1,022,903 $32.8 Million
Q2 2023

Aug 11, 2023

SELL
$17.67 - $31.31 $162,528 - $287,989
-9,198 Reduced 0.91%
1,005,558 $31.5 Million
Q1 2023

May 12, 2023

SELL
$17.13 - $38.52 $22.2 Million - $50 Million
-1,297,751 Reduced 56.12%
1,014,756 $23.1 Million
Q4 2022

Feb 13, 2023

BUY
$29.44 - $37.31 $1.27 Million - $1.61 Million
43,208 Added 1.9%
2,312,507 $78.9 Million
Q3 2022

Nov 14, 2022

SELL
$28.84 - $38.92 $535,876 - $723,172
-18,581 Reduced 0.81%
2,269,299 $69 Million
Q2 2022

Aug 12, 2022

BUY
$33.25 - $45.11 $107,597 - $145,975
3,236 Added 0.14%
2,287,880 $85.2 Million
Q1 2022

May 12, 2022

BUY
$40.68 - $49.72 $698,434 - $853,642
17,169 Added 0.76%
2,284,644 $104 Million
Q4 2021

Feb 10, 2022

BUY
$43.21 - $57.6 $2.47 Million - $3.29 Million
57,140 Added 2.59%
2,267,475 $109 Million
Q3 2021

Nov 09, 2021

SELL
$52.8 - $60.32 $73,761 - $84,267
-1,397 Reduced 0.06%
2,210,335 $123 Million
Q2 2021

Aug 11, 2021

BUY
$51.29 - $59.15 $113 Million - $131 Million
2,211,732 New
2,211,732 $120 Million

Others Institutions Holding SRDX

About SURMODICS INC


  • Ticker SRDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 14,005,000
  • Market Cap $589M
  • Description
  • Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device s...
More about SRDX
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.